Status:
COMPLETED
Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study
Lead Sponsor:
Beckman Coulter, Inc.
Conditions:
Heart Failure
Eligibility:
All Genders
22+ years
Brief Summary
The goal is to establish clinical performance of a BNP assay on the intended use population and establish clinical concordance on a separate device.
Eligibility Criteria
Inclusion
- There is no direct inclusion criteria for this study, Samples were collected under a separate enrollment protocol
Exclusion
- Hemolysis observed per CLSIC56A grading scale
- Icterus (bilirubin) observed 4+ per CLSIC56A grading scale
Key Trial Info
Start Date :
October 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 25 2025
Estimated Enrollment :
1361 Patients enrolled
Trial Details
Trial ID
NCT07217431
Start Date
October 10 2024
End Date
March 25 2025
Last Update
October 16 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland-Baltimore
Baltimore, Maryland, United States, 21201
2
HealthPartners Central Laboratory
Eden Prairie, Minnesota, United States, 55344
3
Hennepin Healthcare Research Institute
Minneapolis, Minnesota, United States, 55404